http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#Head
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion
http://purl.obolibrary.org/obo/DOID_1588
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1588
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01109
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
http://www.w3.org/2000/01/rdf-schema#label
"The use of Heparin Sodium in 0.45% Sodium Chloride Injection or Heparin Sodium in 5% Dextrose Injection is contraindicated in patients with the following conditions: History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT) [see Warnings and Precautions ( 5.3 Known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see Adverse Reactions ( 6.1 In whom suitable blood coagulation tests -- e.g., the whole blood clotting time, partial thromboplastin time, etc., -- cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin) [see Warnings and Precautions ( 5.5 An uncontrolled bleeding state [see Warnings and Precautions ( 5.2 History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT) ( 4 Known hypersensitivity to heparin or pork products ( 4 In whom suitable blood coagulation tests cannot be performed at appropriate intervals ( 4"
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01109
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig
http://purl.org/nanopub/x/hasSignature
BFfWhquQcweGbbmG3CXU8oZvIQBybUOWUtk1EdkcsogC6s9C+k/IT4m/+KuuGGMX6yntISm/TM4HeF/Mq9z1j8eNiyFwgSt+4+qS0PTSd1lbl7X+yyDUFurTwqvhxKRwfCjQ3pjFBSsbIZTmGOm5XFI+m5SNYm0vPp5Jowu0GTU=
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://purl.org/dc/terms/created
2021-08-23T18:57:43.341+02:00
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY